Cargando…
Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens
Mathematical models of drug action and disease progression can inform pediatric pharmacotherapy. In this tutorial, we explore the key issues that differentiate pediatric from adult pharmacokinetic (PK) / pharmacodynamic (PD) studies, describe methods to calculate the number of participants to be enr...
Autores principales: | Stockmann, C, Barrett, JS, Roberts, JK, Sherwin, CMT |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716585/ https://www.ncbi.nlm.nih.gov/pubmed/26783499 http://dx.doi.org/10.1002/psp4.12038 |
Ejemplares similares
-
Design and Conduct Considerations for First‐in‐Human Trials
por: Shen, Jie, et al.
Publicado: (2018) -
Design and conduct considerations for studies in patients with hepatic impairment
por: Ravenstijn, Paulien, et al.
Publicado: (2022) -
Building an adaptive dose simulation framework to aid dose and schedule selection
por: Hooijmaijers, Richard, et al.
Publicado: (2023) -
Tutorial for $DESIGN in NONMEM: Clinical trial evaluation and optimization
por: Bauer, Robert J., et al.
Publicado: (2021) -
Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
por: Maharaj, A R, et al.
Publicado: (2014)